Accelerate Diagnostics, Inc Quarterly Operating Income (Loss) in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Accelerate Diagnostics, Inc quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q3 2024.
  • Accelerate Diagnostics, Inc Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.62M, a 41.2% increase year-over-year.
  • Accelerate Diagnostics, Inc Operating Income (Loss) for the twelve months ending September 30, 2024 was -$38.1M, a 33.4% increase year-over-year.
  • Accelerate Diagnostics, Inc annual Operating Income (Loss) for 2023 was -$54M, a 14% increase from 2022.
  • Accelerate Diagnostics, Inc annual Operating Income (Loss) for 2022 was -$62.8M, a 12.2% increase from 2021.
  • Accelerate Diagnostics, Inc annual Operating Income (Loss) for 2021 was -$71.6M, a 12.3% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$38.1M -$8.62M +$6.03M +41.2% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$44.1M -$8.61M +$3.98M +31.6% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$48.1M -$10.2M +$5.91M +36.8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-13
Q4 2023 -$54M -$10.7M +$3.23M +23.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-29
Q3 2023 -$57.3M -$14.7M +$311K +2.08% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$57.6M -$12.6M +$5.4M +30% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$63M -$16.1M -$167K -1.05% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-13
Q4 2022 -$62.8M -$14M +$5.45M +28.1% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 -$68.3M -$15M -$429K -2.95% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$67.8M -$18M -$399K -2.27% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$67.4M -$15.9M +$4.13M +20.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$71.6M -$19.4M -$4.33M -28.7% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$67.2M -$14.5M +$633K +4.17% Jul 1, 2021 Sep 30, 2021 10-K 2023-03-31
Q2 2021 -$67.9M -$17.6M -$1.87M -11.9% Apr 1, 2021 Jun 30, 2021 10-K 2023-03-31
Q1 2021 -$66M -$20M -$2.3M -13% Jan 1, 2021 Mar 31, 2021 10-K 2023-03-31
Q4 2020 -$63.7M -$15.1M +$3.19M +17.5% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-14
Q3 2020 -$66.9M -$15.2M +$2.49M +14.1% Jul 1, 2020 Sep 30, 2020 10-K 2022-03-14
Q2 2020 -$69.4M -$15.7M +$2.36M +13.1% Apr 1, 2020 Jun 30, 2020 10-K 2022-03-14
Q1 2020 -$71.7M -$17.7M +$1.09M +5.8% Jan 1, 2020 Mar 31, 2020 10-K 2022-03-14
Q4 2019 -$72.8M -$18.3M +$1.49M +7.54% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-02
Q3 2019 -$74.3M -$17.7M +$1.72M +8.86% Jul 1, 2019 Sep 30, 2019 10-K 2021-03-02
Q2 2019 -$76M -$18.1M +$2.33M +11.4% Apr 1, 2019 Jun 30, 2019 10-K 2021-03-02
Q1 2019 -$78.4M -$18.8M +$2M +9.62% Jan 1, 2019 Mar 31, 2019 10-K 2021-03-02
Q4 2018 -$80.4M -$19.8M -$3.62M -22.5% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$76.7M -$19.4M -$2.05M -11.9% Jul 1, 2018 Sep 30, 2018 10-K 2020-02-28
Q2 2018 -$74.7M -$20.4M -$3.99M -24.3% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-28
Q1 2018 -$70.7M -$20.8M -$6.52M -45.5% Jan 1, 2018 Mar 31, 2018 10-K 2020-02-28
Q4 2017 -$64.2M -$16.1M -$112K -0.7% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$64.1M -$17.3M +$101K +0.58% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-01
Q2 2017 -$64.2M -$16.4M +$1.47M +8.2% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-01
Q1 2017 -$65.6M -$14.3M +$862K +5.68% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-01
Q4 2016 -$66.5M -$16M -$2.86M -21.7% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-01
Q3 2016 -$63.6M -$17.4M -$6.21M -55.4% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-01
Q2 2016 -$57.4M -$17.9M -$5.62M -45.8% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-01
Q1 2016 -$51.8M -$15.2M -$6.26M -70.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-01
Q4 2015 -$45.5M -$13.2M -$4.91M -59.5% Oct 1, 2015 Dec 31, 2015 10-K 2018-03-01
Q3 2015 -$40.6M -$11.2M -$2.38M -27% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$38.3M -$12.3M -$4.1M -50.3% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-08
Q1 2015 -$34.2M -$8.91M -$3.16M -55.1% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$31M -$8.25M -$3.07M -59.1% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-28
Q3 2014 -$27.9M -$8.83M -$5.03M -132% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-02
Q2 2014 -$22.9M -$8.17M -$4.39M -116% Apr 1, 2014 Jun 30, 2014 10-Q 2015-07-31
Q1 2014 -$18.5M -$5.75M -$3.2M -125% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-07
Q4 2013 -$15.3M -$5.19M Oct 1, 2013 Dec 31, 2013 10-K 2016-03-09
Q3 2013 -$3.8M -$1.96M -106% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-04
Q2 2013 -$3.78M -$2.63M -230% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-01
Q1 2013 -$2.55M -$2.23M -704% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-02
Q3 2012 -$3.65M -$1.84M -$1.41M -328% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-08
Q2 2012 -$2.24M -$1.15M -$868K -312% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-09
Q1 2012 -$1.37M -$317K -$183K -137% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 -$1.19M -$344K -$296K -621% Nov 1, 2011 Jan 31, 2012 10-Q 2012-03-15
Q3 2011 -$889K -$430K -$480K -960% Aug 1, 2011 Oct 31, 2011 10-Q 2012-12-14
Q2 2011 -$409K -$278K May 1, 2011 Jul 31, 2011 10-K 2014-03-07
Q1 2011 -$134K Feb 1, 2011 Apr 30, 2011 10-Q/A 2012-06-15
Q4 2010 -$47.6K Nov 1, 2010 Jan 31, 2011 10-Q 2012-03-15
Q3 2010 $50K Aug 1, 2010 Oct 31, 2010 10-Q 2011-12-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.